Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness

Background: Fatigue is a frequent symptom in multiple sclerosis (MS) and often interrelated with depression and sleep disorders making symptomatic treatment decisions difficult. In the single-arm, observational phase IV TYNERGY study, relapsing–remitting MS patients showed a clinically meaningful de...

Descripción completa

Detalles Bibliográficos
Autores principales: Penner, Iris-Katharina, Sivertsdotter, Eva Catharina, Celius, Elisabeth G., Fuchs, Siegrid, Schreiber, Karen, Berkö, Sara, Svenningsson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337367/
https://www.ncbi.nlm.nih.gov/pubmed/25755648
http://dx.doi.org/10.3389/fneur.2015.00018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337367/
https://www.ncbi.nlm.nih.gov/pubmed/25755648
http://dx.doi.org/10.3389/fneur.2015.00018

Ejemplares similares